Syrma SGS Technology Ltd. makes a corporate announcement

Q1 FY27’s mix shift was EBITDA-margin dilutive sequentially: Consumer rose from 26% to 34% of revenue while Industrials fell from 31% to 24%, and management attributed the operating EBITDA margin decline from 11.3% in Q4 FY26 to 10.1% in Q1 FY27 primarily to the higher Consumer mix. ^{[1] [2]}

The underlying revenue movements were also asymmetric: Consumer revenue increased 39% QoQ from Rs 382.7 Crores to Rs 532.8 Crores, while Industrials declined 18% QoQ from Rs 458.5 Crores to Rs 376.6 Crores. ^[2] Management linked the Industrial weakness mainly to the seasonal, second-half-loaded maritime business and softer smart-metering uptake, rather than to a deterioration in the broader Industrial opportunity. ^{[5] [6]}

Does this align with the margin-expansion strategy? Directionally yes, but not in the quarter’s mix outcome. Management’s strategy is to keep Consumer at roughly 30–32% of annual revenue, while increasing the contribution of exports, ODM, MedTech, defence and other higher-value businesses. ^{[1] [7]} Exports reached approximately 24% of operating revenue and ODM approximately 17% in Q1 FY27; management said the stronger export and ODM contribution substantially absorbed the negative margin effect of the higher Consumer mix. ^{[8] [5]}

Therefore, Q1 demonstrates the mechanism of the strategy but not yet its full quarterly result: Consumer concentration temporarily compressed the margin, while higher-margin exports and ODM prevented a sharper decline. Management retained its full-year operating EBITDA-margin guidance of 10.5–11%, expecting Consumer seasonality to moderate over the year. ^[9]

Analyst read: the margin-expansion thesis remains dependent on mix normalization and continued scaling of exports/ODM. The Industrial-to-Consumer shift was a short-term headwind; the strategy is aligned only if the current 34% Consumer contribution proves seasonal and the higher-margin businesses continue to grow faster.

The disclosed utilization rate is 65–70% for the company’s current capacity base, but Syrma has not reported a separate utilization rate for the newly expanded facilities. Management indicated that new capacity can initially operate at roughly 40–50% utilization in its first year and potentially ramp toward 80%+, but this is a general ramp-up framework rather than an actual rate for Jodhpur, Pune, or the additional Bangalore capacity. ^{[10] [10] [9]}

The Jodhpur medical plastics and precision-molding facility was inaugurated on 22 September 2026 and is spread over more than 120,000 sq. ft.; the inauguration disclosure did not provide an operating utilization metric. ^{[11] [12]}

P&L impact

On a consolidated basis, the Q1 FY27 P&L shows a modest sequential increase in both relevant cost lines:

• Source values are reported in Rs million and converted to Crores; Q1 FY27 depreciation is also reported as Rs 22.49 Crores and finance cost as Rs 13.34 Crores in the structured financial data.* ^{[13] [13] [14] [15]}
• Depreciation: increased by approximately Rs 1.1 Crores sequentially and Rs 1.9 Crores year-on-year, consistent with a gradual commissioning-related increase in the asset base. However, the filings do not attribute the increase specifically to the new facilities.
• Finance cost: increased only marginally sequentially and remained below the year-ago level. The Q1 FY27 earnings call disclosed total quarterly capex of approximately Rs 90 Crores, including around Rs 50 Crores for the PCB project, while also noting that higher borrowings during the quarter were primarily linked to working-capital and inventory requirements rather than explicitly to facility capex. ^{[16] [16]}
• Analytical read: the expansion has not yet produced a material interest-cost burden in the reported P&L. The immediate accounting effect is more visible in depreciation, while the larger earnings sensitivity remains the pace at which the new capacity is utilized. The P&L does not provide facility-level depreciation or interest attribution, so the exact impact of the Jodhpur and other new facilities cannot be isolated.*

Syrma SGS currently screens better than Kaynes on consolidated working-capital efficiency: its Q1 FY27 TTM-based cash conversion cycle is approximately 37 days versus about 125 days for Kaynes, while inventory turnover is 4.33x versus 2.71x. The recent raw-material build is therefore a watchpoint, but it has not yet translated into weaker reported inventory velocity.

Q1 FY27 TTM-based comparison

CCC is derived as: inventory days + receivable days − payable days. Receivable days are derived as 365 / debtor turnover.

The ratios are TTM-based Q1 FY27 proxies, not reported quarter-end CCC figures. Syrma and Kaynes are the closest direct EMS comparison. HONAUT is a mixed automation business spanning manufacturing, trading and services, while Jyoti CNC is a CNC-machine manufacturer and Tega is a mining and mineral-processing products company; their figures are directional rather than pure EMS benchmarks. ^{[37] [38] [39]}

What the raw-material stocking changes

Syrma’s consolidated raw-material closing stock increased from Rs 636.26 Crores in FY25 to Rs 765.77 Crores in FY26, a derived increase of 20.36%. The figures are reported in million Indian rupees in the annual-report note and converted here into Crores. ^{[40] [40]}

The increase should be read alongside the flow data:

• Raw-material purchases rose by 33.86%, while consumption rose by 24.09%, both derived from the annual-report figures. ^[40]
• Total consolidated inventories rose 29.2% YoY in FY26. ^[41]
• Despite that FY26 build, the Q1 FY27 TTM inventory turnover proxy improved from 3.81x in FY26 to 4.33x, while inventory days declined from 95.80 to 84.30. ^{[42] [17] [43] [18]}

Analytical read: the balance-sheet increase is real and purchases grew faster than consumption, consistent with procurement ahead of production or customer shipments. However, the subsequent TTM ratios do not currently show inventory stagnation: Syrma’s inventory days remain roughly 50 days lower than Kaynes’, and its higher payable days also support the shorter CCC. The trade-off is that part of Syrma’s cash-cycle advantage is being funded through supplier credit, rather than coming solely from faster customer collections.

Kaynes’ management separately reported FY26 overall working-capital days of 122, versus 53 days for its core EMS business, because the smart-metering business has a structurally longer cycle. ^[44] Syrma’s FY26 reported net working-capital days were 63, although that management-defined metric is not identical to the formal CCC calculated above. ^[45]

Bottom line: Syrma’s current consolidated working-capital position is materially stronger than Kaynes’ on the standardized TTM proxy, and the raw-material stocking has not yet impaired inventory turnover. The key monitor is whether inventory days remain near the current 84-day level while payable days normalize; a reversal toward the FY26 96-day inventory level without corresponding revenue or consumption growth would make the stocking more concerning.

_Scope note: this comparison also included Aditya Infotech Limited (CPPLUS), which the answer above does not cover. Ask about any of them for a full side-by-side._